RFL scam: Court rejects bail plea of ex-Fortis Healthcare promoter Shivinder Singh
Singh's brother Malvinder (46), also a former Fortis Healthcare promoter, Sunil Godhwani (58), Kavi Arora (48) and Anil Saxena were arrested by the Economic Offences Wing (EOW) of Delhi Police for allegedly diverting RFL's money and investing in other companies.
Buy Cadila Healthcare, price target Rs 295: Kunal Bothra
The analyst suggested a stoploss at Rs 250.
Buy Cadila Healthcare, price target Rs 278: Sagar Doshi
The analyst suggested a stoploss at Rs 245.
ED arrests Former Religare Promoter Shivinder Singh
Shivinder Singh was in judicial custody after the Delhi Police's Economic Offences Wing had arrested him and others recently. A Delhi Court had on Thursday rejected his bail plea in this police case. The ED had earlier arrested Shivinder Singh's brother Malvinder Mohan Singh in this case.
Hospital stocks turn safe bets amid uncertain times
Investors are now looking at hospitals as many large pharma cos are facing regulatory issues.
ET ILC members discuss possibility of integrated healthcare system in India
Integrated healthcare at a macro level means managing the overall well-being of the nation by putting the consumer at the centre; it involves delivering the required level of efficient and quality care to the consumers across their lifetime.
Top intraday trading ideas for afternoon trade on Wednesday, December 11, 2019
Cadila Healthcare is a 'Buy' call with a target price of Rs 295 and a stop loss of Rs 250.
Singhs had nothing to do with Fortis when IHH invested in it: Rakesh Jhunjhunwala
Ace stock market investor says IHH Healthcare's open offer for Fortis is fair and should be allowed.
It's all about the money: Salary package most important for freshers, delayed response from employers a major turn-off
Traditional benefits like healthcare coverage, retirement plans & life insurance are preferred.
Spicy investment! Ditch onions for these stocks to make a quick buck
Of the 2,213 actively-traded stocks on BSE, as many as 1,488 now trade below Rs 140.
Primary healthcare is failing 80 crore Indians. An app may be the antidote
Rural India suffers from the paucity of primary healthcare centres. By taking doctor consultations online through an app and providing safe record keeping of patients, MedCords wants to address one of the key issues for patients in rural India.
USV in talks with Novartis to buy Jalra Trademark for Rs. 200 Crore
Mumbai-based drugmaker USV Pvt Ltd is in advanced discussions to acquire the trademark for antidiabetes drug Jalra from Novartis for a deal valued at more than Rs. 200 crore.
Govt healthcare institutions can consider developing training courses for caregivers: President Kovind
The president was speaking at an event to present the National Florence Nightingale Awards to 36 nurses for their meritorious services in the healthcare sector. Kerala's Lini Puthussery, who died due to Nipah virus infection in May last year, was awarded posthumously for her "unsurpassed dedication in taking care of patients during the Nipah virus outbreak in the state".
Geojit maintains hold on Cadila Healthcare, target price Rs 270
The stock closed Rs 259, up 1.6 per cent on Thursday.
Zydus Cadila files NDA for Saroglitazar Magnesium
NASH is a progressive disease of the liver and a significant unmet medical need. There are currently no treatments available for the treatment of NASH. aroglitazar Mg has previously demonstrated improvement in both liver enzymes along with favorable effects on lipid and glycemic indices in patients with nonalcoholic fatty liver disease in Phase II clinical trials.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service